ar %D8%B9%D8%A7%D9%85%D9%84 %D8%A7%D9%84%D9%86%D9%85%D9%88 %D8%A7%D9%84%D9%85%D8%AD%D9%88%D9%84 %D8%A8%D9%8A%D8%AA%D8%A7 1

Transforming growth factor, beta 1
Transforming growth factor, beta 1
	بنك بيانات البروتينات rendering based on 1kla.
التراكيب المتوفرة
بنك بيانات البروتين	بحث أورثولوغ: PDBe, RCSB
قائمة رموز معرفات بنك بيانات البروتين
	1KLA, 1KLC, 1KLD, 3KFD, 4KV5
المعرفات
الرمز، (أو الرموز)	TGFB1; CED; DPD1; LAP; TGFB; TGFbeta
معرفات خارجية	OMIM: 190180 MGI: 98725 هومولوجين: 540 مختبر علم الأحياء الجزيئي الأوروبي الكيميائي: 1795178 بطاقات الجينات: TGFB1 Gene
علم الوجود الجيني
الوظيفة الجزيئية	• glycoprotein binding; • antigen binding; • type II transforming growth factor beta receptor binding; • cytokine activity; • protein binding; • growth factor activity; • enzyme binding; • type I transforming growth factor beta receptor binding; • type III transforming growth factor beta receptor binding; • protein homodimerization activity; • protein heterodimerization activity; • protein N-terminus binding;
المكونات الخلوية	• extracellular region; • proteinaceous extracellular matrix; • extracellular space; • nucleus; • cytoplasm; • Golgi lumen; • plasma membrane; • microvillus; • cell surface; • axon; • platelet alpha granule lumen; • neuronal cell body; • blood microparticle;
العملية الإحيائية	• protein import into nucleus, translocation; • negative regulation of transcription from RNA polymerase II promoter; • MAPK cascade; • ureteric bud development; • response to hypoxia; • epithelial to mesenchymal transition; • negative regulation of protein phosphorylation; • positive regulation of protein phosphorylation; • regulation of sodium ion transport; • chondrocyte differentiation; • hematopoietic progenitor cell differentiation; • connective tissue replacement involved in inflammatory response wound healing; • adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains; • tolerance induction to self antigen; • platelet degranulation; • protein phosphorylation; • protein export from nucleus; • ATP biosynthetic process; • phosphate-containing compound metabolic process; • cellular calcium ion homeostasis; • inflammatory response; • cell cycle arrest; • mitotic cell cycle checkpoint; • epidermal growth factor receptor signaling pathway; • transforming growth factor beta receptor signaling pathway; • common-partner SMAD protein phosphorylation; • SMAD protein complex assembly; • SMAD protein import into nucleus; • negative regulation of neuroblast proliferation; • salivary gland morphogenesis; • endoderm development; • female pregnancy; • aging; • blood coagulation; • negative regulation of DNA replication; • positive regulation of cell proliferation; • negative regulation of cell proliferation; • germ cell migration; • response to radiation; • response to wounding; • response to glucose; • defense response to fungus, incompatible interaction; • positive regulation of vascular endothelial growth factor production; • positive regulation of gene expression; • negative regulation of gene expression; • negative regulation of extracellular matrix disassembly; • positive regulation of epithelial to mesenchymal transition; • macrophage derived foam cell differentiation; • positive regulation of fibroblast migration; • positive regulation of peptidyl-threonine phosphorylation; • positive regulation of pathway-restricted SMAD protein phosphorylation; • negative regulation of macrophage cytokine production; • oligodendrocyte development; • cell growth; • regulation of striated muscle tissue development; • regulation of transforming growth factor beta receptor signaling pathway; • modulation by virus of host morphology or physiology; • evasion or tolerance of host defenses by virus; • viral life cycle; • negative regulation of cell-cell adhesion; • platelet activation; • extracellular matrix organization; • hyaluronan catabolic process; • negative regulation of ossification; • negative regulation of cell growth; • regulation of cell migration; • positive regulation of cell migration; • positive regulation of bone mineralization; • negative regulation of transforming growth factor beta receptor signaling pathway; • positive regulation of histone deacetylation; • organ regeneration; • positive regulation of protein complex assembly; • positive regulation of exit from mitosis; • lipopolysaccharide-mediated signaling pathway; • positive regulation of cellular protein metabolic process; • response to estradiol; • response to progesterone; • regulation of interleukin-23 production; • negative regulation of interleukin-17 production; • positive regulation of interleukin-17 production; • receptor catabolic process; • positive regulation of superoxide anion generation; • mononuclear cell proliferation; • positive regulation of collagen biosynthetic process; • positive regulation of peptidyl-serine phosphorylation; • response to vitamin D; • response to laminar fluid shear stress; • positive regulation of histone acetylation; • positive regulation of protein dephosphorylation; • negative regulation of T cell proliferation; • regulation of protein import into nucleus; • positive regulation of protein import into nucleus; • positive regulation of odontogenesis; • response to drug; • myelination; • regulation of apoptotic process; • myeloid dendritic cell differentiation; • T cell homeostasis; • positive regulation of apoptotic process; • positive regulation of MAP kinase activity; • protein kinase B signaling; • positive regulation of blood vessel endothelial cell migration; • negative regulation of blood vessel endothelial cell migration; • positive regulation of phosphatidylinositol 3-kinase activity; • ossification involved in bone remodeling; • regulatory T cell differentiation; • cell-cell junction organization; • negative regulation of cell differentiation; • negative regulation of fat cell differentiation; • negative regulation of myoblast differentiation; • negative regulation of cell cycle; • negative regulation of transcription, DNA-templated; • positive regulation of transcription, DNA-templated; • negative regulation of mitotic cell cycle; • positive regulation of transcription from RNA polymerase II promoter; • active induction of host immune response by virus; • positive regulation of isotype switching to IgA isotypes; • cell development; • lymph node development; • digestive tract development; • negative regulation of skeletal muscle tissue development; • inner ear development; • positive regulation of epithelial cell proliferation; • negative regulation of epithelial cell proliferation; • positive regulation of protein secretion; • negative regulation of phagocytosis; • positive regulation of chemotaxis; • positive regulation of NF-kappaB transcription factor activity; • regulation of binding; • regulation of DNA binding; • positive regulation of smooth muscle cell differentiation; • negative regulation of release of sequestered calcium ion into cytosol; • positive regulation of protein kinase B signaling; • regulation of blood vessel remodeling; • face morphogenesis; • frontal suture morphogenesis; • pathway-restricted SMAD protein phosphorylation; • positive regulation of SMAD protein import into nucleus; • SMAD protein signal transduction; • mammary gland branching involved in thelarche; • branch elongation involved in mammary gland duct branching; • regulation of branching involved in mammary gland duct morphogenesis; • negative regulation of gene silencing by miRNA; • regulation of cartilage development; • lens fiber cell differentiation; • response to cholesterol; • positive regulation of cell cycle arrest; • cellular response to organic cyclic compound; • cellular response to dexamethasone stimulus; • cellular response to transforming growth factor beta stimulus; • extracellular matrix assembly; • positive regulation of branching involved in ureteric bud morphogenesis; • extrinsic apoptotic signaling pathway; • negative regulation of hyaluronan biosynthetic process; • positive regulation of extracellular matrix assembly; • positive regulation of NAD+ ADP-ribosyltransferase activity; • regulation of actin cytoskeleton reorganization; • positive regulation of transcription regulatory region DNA binding;
	المصادر: Amigo / QuickGO
نمط التعبير عن الحمض النووي الريبوزي
	مصادر أخرى عن بيانات أنماط التعبير
التقويمات
الأنواع	الإنسان
أنتريه	7040
انسمبل	ENSG00000105329
يونيبروت	P01137
قاعدة بيانات مرجعية (مرسال ر.ن.ا)	NM_000660
قاعدة بيانات مرجعية (بروتين)	NP_000651
الموقع (قاعدة بيانات UCSC)	Chr 19:; 41.3 – 41.35 Mb
بحث ببمد	[1]
	ع; ن; ت;

معلومات عامة
صنف فرعي من	جين يشفر بروتين
وُجد في الأصنوفة	إنسان عاقل
الجين يُشفِر	transforming growth factor beta 1 (en)
الصبغي	صبغي 19
التوجه الجيني	reverse strand (en)
بداية المجموع المورثي	41301587; 41807492
نهاية المجموع المورثي	41859816; 41353922
الموضع الصبغوي	19q13.2
معرف هومولوجين	540
يتماثل مع	Tgfb1 (en) ; Tgfb1 (en) ; tgfb1a (en) ; tgfb1b (en)
تم التعبير عنه في	القائمة ... خلية محببة; خلية وحيدة; stromal cell of endometrium (en) ; أبهر صاعد; Descending thoracic aorta (en) ; شريان تاجي أيمن; طحال; الرئة اليمنى; قناة عنق الرحم; دم

عامل النمو المحول بيتا 1 (TGF-β1) هو بروتين يتبع عائلة عامل النمو المحول التابعة لمجموعة السيتوكين. يساهم هذه البروتين في عدد من الوظائف الخلوية مثل تكاثر ونمو الخلايا والتمايز الخلوي والااستماتة.^[8]^[9]

انظر أيضًا

عامل النمو المحول بيتا

مصادر

^ مذكور في: Ensembl Release 87. معرف إنزمبل جين: ENSG00000105329. تاريخ النشر: ديسمبر 2016.
^ ^ا ^ب ^ج ^د ^ه ^و ^ز مذكور في: ensembl Release 106. معرف إنزمبل جين: ENSG00000105329.
^ مذكور في: يونيبروت. الوصول: 6 يوليو 2017. معرف يونيبروت: P01137. لغة العمل أو لغة الاسم: الإنجليزية.
^ ^ا ^ب مذكور في: NCBI Gene. الوصول: 15 مايو 2022. معرف جين أنتريه: 7040.
^ ^ا ^ب ^ج ^د مذكور في: HomoloGene build68. معرف هومولوجين: 540. تاريخ النشر: 9 أبريل 2014.
^ ^ا ^ب ^ج ^د "Orthologous MAtrix".
^ ^ا ^ب ^ج ^د ^ه ^و ^ز ^ح ^ط ^ي "Bgee". اطلع عليه بتاريخ 2024-06-07.
^ Ghadami M، Makita Y، Yoshida K، Nishimura G، Fukushima Y، Wakui K، Ikegawa S، Yamada K، Kondo S، Niikawa N، Tomita Ha (يناير 2000). "Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3". Am. J. Hum. Genet. ج. 66 ع. 1: 143–7. DOI:10.1086/302728. PMC:1288319. PMID:10631145.
^ Vaughn SP، Broussard S، Hall CR، Scott A، Blanton SH، Milunsky JM، Hecht JT (مايو 2000). "Confirmation of the mapping of the Camurati-Englemann locus to 19q13. 2 and refinement to a 3.2-cM region". Genomics. ج. 66 ع. 1: 119–21. DOI:10.1006/geno.2000.6192. PMID:10843814.

هذه بذرة مقالة عن بروتين بحاجة للتوسيع. فضلًا شارك في تحريرها.

[6df5653edee42391a84d998bb4437d41b5737e6b-1] مذكور في: Ensembl Release 87. معرف إنزمبل جين: ENSG00000105329. تاريخ النشر: ديسمبر 2016.

[f9567cfffbeee2344756c72239aca63383e8aea9-2] ا ^ب ^ج ^د ^ه ^و ^ز مذكور في: ensembl Release 106. معرف إنزمبل جين: ENSG00000105329.

[f14e598b35c68ec2bc27df1af1ef6b7609c543ed-3] مذكور في: يونيبروت. الوصول: 6 يوليو 2017. معرف يونيبروت: P01137. لغة العمل أو لغة الاسم: الإنجليزية.

[f56a6d73f1f3d9de3180b909a8640684622987b8-4] ا ^ب مذكور في: NCBI Gene. الوصول: 15 مايو 2022. معرف جين أنتريه: 7040.

[df422dcbbffe172b86671b2133de104ffe34a5fb-5] ا ^ب ^ج ^د مذكور في: HomoloGene build68. معرف هومولوجين: 540. تاريخ النشر: 9 أبريل 2014.

[c688d0a4b54259f39840fb6327d33aaa711b3dba-6] ا ^ب ^ج ^د "Orthologous MAtrix".

[d7d8b5686e6dc0f816472a3e2091e3edc81f4501-7] ا ^ب ^ج ^د ^ه ^و ^ز ^ح ^ط ^ي "Bgee". اطلع عليه بتاريخ 2024-06-07.

[pmid10631145-8] Ghadami M، Makita Y، Yoshida K، Nishimura G، Fukushima Y، Wakui K، Ikegawa S، Yamada K، Kondo S، Niikawa N، Tomita Ha (يناير 2000). "Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3". Am. J. Hum. Genet. ج. 66 ع. 1: 143–7. DOI:10.1086/302728. PMC:1288319. PMID:10631145.

[pmid10843814-9] Vaughn SP، Broussard S، Hall CR، Scott A، Blanton SH، Milunsky JM، Hecht JT (مايو 2000). "Confirmation of the mapping of the Camurati-Englemann locus to 19q13. 2 and refinement to a 3.2-cM region". Genomics. ج. 66 ع. 1: 119–21. DOI:10.1006/geno.2000.6192. PMID:10843814.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]